[1] |
Pope III CA, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA, 2002; 287, 1132−41. doi: 10.1001/jama.287.9.1132 |
[2] |
Tomczak A, Miller AB, Weichenthal SA, et al. Long-term exposure to fine particulate matter air pollution and the risk of lung cancer among participants of the Canadian National Breast Screening Study. Int J Cancer, 2016; 139, 1958−66. doi: 10.1002/ijc.30255 |
[3] |
de Perrot M, Licker M, Bouchardy C, et al. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg, 2000; 119, 21−6. doi: 10.1016/S0022-5223(00)70213-3 |
[4] |
Márquez-Garbán DC, Chen HW, Fishbein MC, et al. Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroidsm, 2007; 72, 135−43. doi: 10.1016/j.steroids.2006.11.019 |
[5] |
Brueckl WM, Al-Batran SE, Ficker JH, et al. Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer. Int J Cancer, 2013; 133, 1825−31. doi: 10.1002/ijc.28209 |
[6] |
Siegfried JM, Stabile LP. Estrogenic steroid hormones in lung cancer. Semin Oncol, 2014; 41, 5−16. doi: 10.1053/j.seminoncol.2013.12.009 |
[7] |
Zhang GF, Yanamala N, Lathrop KL, et al. Ligand-independent antiapoptotic function of estrogen receptor-β in lung cancer cells. Mol Endocrinol, 2010; 24, 1737−47. doi: 10.1210/me.2010-0125 |
[8] |
Gomez-Fernandez C, Mejias A, Walker G, et al. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor. Appl Immunohistochem Mol Morphol, 2010; 18, 137−41. doi: 10.1097/PAI.0b013e3181bec23b |
[9] |
McHugh MK, Lopez MS, Ho CH, et al. Use of the cytokinesis-blocked micronucleus assay (CBMN) to detect gender differences and genetic instability in a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev, 2013; 22, 135−45. doi: 10.1158/1055-9965.EPI-12-0435 |
[10] |
Yang B, Chen DM, Zhao H, et al. The effects for PM2.5 exposure on non-small-cell lung cancer induced motility and proliferation. Springerplus, 2016; 5, 2059. doi: 10.1186/s40064-016-3734-8 |